Table 2.
MEP amplitudes and stimulation intensity before and after drug administration
| TMS parameter | Medication condition | bl1 | bl2 | bl3 |
|---|---|---|---|---|
| MEP | PLC/PLC | 1.06 ± 0.09 | 1.15 ± 0.13 | 1.05 ± 0.07 |
| MSO in % | 48 ± 10.8 | 48,5 ± 11.3 | ||
| MEP | NP/PLC | 1.06 ± 0.06 | 1.04 ± 0.16 | 1.06 ± 0.06 |
| MSO in % | 48.3 ± 10.9 | 49.6 ± 11.9 | ||
| MEP | PLC + FLU 2.5 | 1.08 ± 0.06 | 1.14 ± 0.18 | 1.10 ± 0.05 |
| MSO in % | 48.25 ± 10.1 | 48.25 ± 9.2 | ||
| MEP | PLC + FLU 5 | 1.06 ± 0.09 | 1.11 ± 0.18 | 1.07 ± 0.08 |
| MSO in % | 50.1 ± 13 | 49.3 ± 11.7 | ||
| MEP | PLC + FLU 10 | 1.04 ± 0.09 | 1.12 ± 0.19 | 1.03 ± 0.08 |
| MSO in % | 50.8 ± 10.9 | 50.8 ± 10.7 | ||
| MEP | NP + FLU 2.5 | 1.05 ± 0.08 | 1.15 ± 0.28 | 1.03 ± 0.08 |
| MSO in % | 50.8 ± 10.1 | 49.9 ± 10.6 | ||
| MEP | NP + FLU 5 | 1.05 ± 0.06 | 1.19 ± 0.21 | 1.01 ± 0.05 |
| MSO in % | 48.4 ± 10.7 | 47.3 ± 11.0 | ||
| MEP | NP + FLU 10 | 1.06 ± 0.09 | 1.13 ± 0.22 | 1.03 ± 0.08 |
| MSO in % | 50.1 ± 11.8 | 49.1 ± 12.6 |